Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zili Kong"'
Autor:
Jingwei Chi, Ying Chen, Changgui Li, Shiguo Liu, Kui Che, Zili Kong, Ziheng Guo, Yanchen Chu, Yajing Huang, Libo Yang, Cunwei Sun, Yunyang Wang, Wenshan Lv, Qing Zhang, Hui Guo, Han Zhao, Zhitao Yang, Lili Xu, Ping Wang, Bingzi Dong, Jianxia Hu, Shihai Liu, Fei Wang, Yanyun Zhao, Mengmeng Qi, Yu Xin, Huiqi Nan, Xiangzhong Zhao, Wei Zhang, Min Xiao, Ke Si, Yangang Wang, Yihai Cao
Publikováno v:
Cell Discovery, Vol 10, Iss 1, Pp 1-16 (2024)
Abstract Defective renal excretion and increased production of uric acid engender hyperuricemia that predisposes to gout. However, molecular mechanisms underlying defective uric acid excretion remain largely unknown. Here, we report a rare genetic va
Externí odkaz:
https://doaj.org/article/3d015cb66b844730a1f2621efe357e73
Autor:
Yanyun Zhao, Yue Zhou, Min Xiao, Yajing Huang, Mengmeng Qi, Zili Kong, Jingwei Chi, Kui Che, Wenshan Lv, Bingzi Dong, Yangang Wang
Publikováno v:
Journal of Diabetes, Vol 14, Iss 5, Pp 334-344 (2022)
Abstract Background The purpose of this study is to compare serum pancreatic polypeptide (PP), insulin, C‐peptide, and glucagon in different glucose tolerance stages; analyze the influencing factors of PP secretion; and further explore the role of
Externí odkaz:
https://doaj.org/article/b96454e1ff1d4f3a9481bc6b276210dd
Autor:
Mengmeng Qi, Xianfeng Shao, Ding Li, Yue Zhou, Lili Yang, Jingwei Chi, Kui Che, Yangang Wang, Min Xiao, Yanyun Zhao, Zili Kong, Wenshan Lv
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundDiabetic ketosis (DK) is one of the leading causes of hospitalization among patients with diabetes. Failure to recognize DK symptoms may lead to complications, such as diabetic ketoacidosis, severe neurological morbidity, and death.PurposeT
Externí odkaz:
https://doaj.org/article/f75a06e0ed8845d5a83bd17525c9e52c
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 21(4)
Aims We undertook a systematic review and meta-analysis to assess the efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT2is) concerning kidney outcomes in patients with type 2 diabetes mellitus (T2DM), with or without prevalent ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8e68c8909a95138225bf47839d51af4
https://pubmed.ncbi.nlm.nih.gov/30565382
https://pubmed.ncbi.nlm.nih.gov/30565382